Stage – II testicular Teratoma is treated by:
Stage II in testicular cancer typically means that the cancer has spread beyond the testicle but hasn't reached the lymph nodes in the abdomen or pelvis yet. Wait, no, actually, the staging might be different. Let me think. The staging for testicular cancer uses the TNM system. Stage I is limited to the testis, Stage II involves retroperitoneal lymph nodes, and Stage III is distant metastasis. So Stage II is regional lymph node involvement.
Testicular teratomas are usually non-seminomatous germ cell tumors (NSGCT). The treatment for NSGCT depends on the stage. For Stage II, after orchiectomy (surgical removal of the testicle), the standard treatment is usually chemotherapy followed by radiation or surveillance, depending on the specific subtype and other factors. Alternatively, some sources mention that for certain stages, retroperitoneal lymph node dissection (RPLND) might be considered, but I think that's more for seminomas.
Wait, but I remember that for non-seminomatous germ cell tumors, the primary treatment after surgery is chemotherapy, like BEP (bleomycin, etoposide, cisplatin). Radiation is more commonly used for seminomas. So for Stage II NSGCT, like teratoma, the main treatment after orchiectomy would be adjuvant chemotherapy. So the correct answer would be chemotherapy.
Looking at the options, the correct answer is likely chemotherapy. Let me check the possible distractors. The options might include radiation, RPLND, or surveillance. Radiation isn't the primary for non-seminomas. RPLND is more for seminomas or for certain cases where there's residual disease. Surveillance might be an option for some early stages but not typically Stage II. So the correct answer is chemotherapy.
**Core Concept**
Stage II testicular teratoma, a non-seminomatous germ cell tumor (NSGCT), requires adjuvant chemotherapy after radical orchiectomy. Staging is based on lymph node involvement (retroperitoneal nodes), and treatment aims to eliminate residual malignant cells.
**Why the Correct Answer is Right**
Stage II teratomas involve retroperitoneal lymph nodes but no distant metastases. The standard adjuvant therapy is **BEP (bleomycin, etoposide, cisplatin)** chemotherapy for 3 cycles. This regimen targets residual tumor cells post-surgery, reducing recurrence risk. Chemotherapy is preferred over radiation for NSGCTs, which are less radiosensitive than seminomas.
**Why Each Wrong Option is Incorrect**
**Option A:** Radiation therapy is ineffective for NSGCTs due to their intrinsic radioresistance.
**Option B:** Retroperitoneal lymph node dissection (RPLND) is used for seminomas or for confirming residual disease in NSGCTs, not as primary adjuvant therapy.
**Option C:** Surveillance alone is insufficient for Stage II disease, where occult metastases are likely.
**Clinical Pearl / High-Yield Fact**
For